glp-1 logo GLP-1 Logo Design Showcasing Modern Branding Elements Stock Photo GLP-1 Rewrites CPG Strategy |

Although these drugs demonstrated effectiveness in improving blood sugar control and promoting weight loss, lawsuits now allege that GLP-1 receptor agonists may also be associated with severe gastrointestinal injuries, optic nerve complications, and other serious adverse health effects

Injectable GLP-1 Medications Weekly injectable options include semaglutide (marketed as Wegovy for weight management and Ozempic for type 2 diabetes) and tirzepatide (marketed as Zepbound for weight management and Mounjaro for type 2 diabetes)

Mean baseline body weight was 106.3 kg, and mean BMI was 38.3 kg/m2

This class includes semaglutide (Ozempic for diabetes, Wegovy for weight management) and liraglutide (Victoza for diabetes, Saxenda for weight management)